OCUL
NASDAQ · Pharmaceuticals
Ocular Therapeutix Inc
$7.14
+0.32 (+4.69%)
Open$7.09
Previous Close$6.82
Day High$7.17
Day Low$6.83
52W High$16.44
52W Low$6.00
Volume—
Avg Volume2.38M
Market Cap1.41B
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+694.1% upside
Current
$7.14
$7.14
Target
$56.70
$56.70
$44.23
$56.70 avg
$95.28
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 54.88M | 54.72M | 384.00M |
| Net Income | -280,903,114 | -252,056,632 | 56.73M |
| Profit Margin | -511.9% | -486.3% | 14.8% |
| EBITDA | -280,646,004 | -265,816,255 | 95.97M |
| Free Cash Flow | — | — | 61.23M |
| Rev Growth | +0.3% | +0.3% | -3.5% |
| Debt/Equity | 0.11 | 0.11 | 0.35 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |